Vitamin D status and chronic obstructive pulmonary disease: A prospective general population study

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Skaaby, Tea ^a   Husemoen, Lise Lotte Nystrup ^a   Thuesen, Betina Heinsbæk ^a   Pisinger, Charlotta ^a   Jørgensen, Torben ^a,b,c   Fenger, Runa Vavia ^a   Linneberg, Allan ^a,b  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c AALBORG UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D;

ADULT; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FOOD INTAKE; FORCED EXPIRATORY VOLUME; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NUTRITIONAL ASSESSMENT; NUTRITIONAL HEALTH; NUTRITIONAL STATUS; POPULATION RESEARCH; TREND STUDY; VITAMIN BLOOD LEVEL; ADOLESCENT; AGED; BLOOD; DENMARK; INCIDENCE; PREVALENCE; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; VITAMIN D DEFICIENCY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CROSS-SECTIONAL STUDIES; DENMARK; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84897144931     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090654     Document Type: Article

References (39)

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ (2006) Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367: 1747-57. (Pubitemid 43767064)
2. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS (2001) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 163: 1256-76. (Pubitemid 32378468)
3. Sethi S (2000) Infectious etiology of acute exacerbations of chronic bronchitis. Chest 117: 380S-5S.
4. Hoogendoorn M, Hoogenveen RT, Rutten-van Molken MP, Vestbo J, Feenstra TL (2011) Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach. Eur Respir J 37: 508-15.
5. From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2014. Available: http://www.goldcopd.org/.
6. Nathell L, Nathell M, Malmberg P, Larsson K (2007) COPD diagnosis related to different guidelines and spirometry techniques. Respir Res 8: 89.
7. Adams JS, Hewison M (2008) Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab 4: 80-90. (Pubitemid 351156900)
8. Pfeffer PE, Hawrylowicz CM (2012) Vitamin D and lung disease. Thorax 67: 1018-20.
9. Persson LJ, Aanerud M, Hiemstra PS, Hardie JA, Bakke PS, et al. (2012) Chronic obstructive pulmonary disease is associated with low levels of vitamin D. PLoS One 7: e38934.
10. Black PN, Scragg R (2005) Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey. Chest 128: 3792-8. (Pubitemid 43062638)
11. Ginde AA, Mansbach JM, Camargo CA, Jr. (2009) Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 169: 384-90.
12. Dobak J, Grzybowski J, Liu FT, Landon B, Dobke M (1994) 1,25-Dihydroxyvitamin D3 increases collagen production in dermal fibroblasts. J Dermatol Sci 8: 18-24.
13. Rasmussen SL, Torp-Pedersen C, Borch-Johnsen K, Ibsen H (1998) Normal values for ambulatory blood pressure and differences between casual blood pressure and ambulatory blood pressure: results from a Danish population survey. J Hypertens 16: 1415-24. (Pubitemid 28470488)
14. Jorgensen T, Borch-Johnsen K, Thomsen TF, Ibsen H, Glumer C, et al. (2003) A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. Eur J Cardiovasc Prev Rehabil 10: 377-86. (Pubitemid 38037253)
15. Berg ND, Husemoen LL, Thuesen BH, Hersoug LG, Elberling J, et al. (2012) Interaction between filaggrin null mutations and tobacco smoking in relation to asthma. J Allergy Clin Immunol 129: 374-80, 380.
16. Carter GD, Carter R, Jones J, Berry J (2004) How accurate are assays for 25-hydroxyvitamin D? Data from the international vitamin D external quality assessment scheme. Clin Chem 50: 2195-7. (Pubitemid 39425873)
17. Thuesen B, Husemoen L, Fenger M, Jakobsen J, Schwarz P, et al. (2012) Determinants of vitamin D status in a general population of Danish adults. Bone 50: 605-10.
18. Thyssen JP, Thuesen B, Huth C, Standl M, Carson CG, et al. (2012) Skin barrier abnormality caused by filaggrin (FLG) mutations is associated with increased serum 25-hydroxy vitamin D concentrations. J Allergy Clin Immunol.
19. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH (1999) The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 46: 263-8. (Pubitemid 29299976)
20. Juel K, Helweg-Larsen K (1999) The Danish registers of causes of death. Dan Med Bull 46: 354-7. (Pubitemid 29439149)
21. Hersoug LG, Husemoen LL, Sigsgaard T, Madsen F, Linneberg A (2010) Indoor exposure to environmental cigarette smoke, but not other inhaled particulates associates with respiratory symptoms and diminished lung function in adults. Respirology 15: 993-1000.
22. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, et al. (1993) Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 16: 5-40.
23. Skaaby T, Husemoen LL, Pisinger C, Jorgensen T, Thuesen BH, et al. (2012) Vitamin D status and cause-specific mortality: a general population study. PLoS One 7: e52423.
24. Romme EA, Rutten EP, Smeenk FW, Spruit MA, Menheere PP, et al. (2012) Vitamin D status is associated with bone mineral density and functional exercise capacity in patients with chronic obstructive pulmonary disease. Ann Med.
25. Kunisaki KM, Niewoehner DE, Connett JE (2012) Vitamin D levels and risk of acute exacerbations of chronic obstructive pulmonary disease: a prospective cohort study. Am J Respir Crit Care Med 185: 286-90.
26. Holmgaard DB, Mygind LH, Titlestad IL,Madsen H, Fruekilde PB, et al. (2013) Serum vitamin D in patients with chronic obstructive lung disease does not correlate with mortality-results from a 10-year prospective cohort study. PLoS One 8: e53670.
27. Lehouck A, Mathieu C, Carremans C, Baeke F, Verhaegen J, et al. (2012) High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 156: 105-14.
28. Grant WB (2011) Effect of interval between serum draw and follow-up period on relative risk of cancer incidence with respect to 25-hydroxyvitamin D level: Implications for meta-analyses and setting vitamin D guidelines. Dermatoendocrinol 3: 199-204.
29. Grant WB (2012) Effect of follow-up time on the relation between prediagnostic serum 25-hydroxyvitamin D and all-cause mortality rate. Dermatoendocrinol 4: 198-202.
30. Jorde R, Sneve M, Hutchinson M, Emaus N, Figenschau Y, et al. (2010) Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. Am J Epidemiol 171: 903-8.
31. Lynge E, Sandegaard JL, Rebolj M (2011) The Danish National Patient Register. Scand J Public Health 39: 30-3.
32. Thomsen RW, Lange P, Hellquist B, Frausing E, Bartels PD, et al. (2011) Validity and underrecording of diagnosis of COPD in the Danish National Patient Registry. Respir Med 105: 1063-8.
33. Wielders JP, Wijnberg FA (2009) Preanalytical stability of 25(OH)-vitamin D3 in human blood or serum at room temperature: solid as a rock. Clin Chem 55: 1584-5.
34. Ocke MC, Schrijver J, Obermann-de Boer GL, Bloemberg BP, Haenen GR, et al. (1995) Stability of blood (pro)vitamins during four years of storage at -20 degrees C: consequences for epidemiologic research. J Clin Epidemiol 48: 1077-85.
35. Snellman G, Melhus H, Gedeborg R, Byberg L, Berglund L, et al. (2010) Determining vitamin D status: a comparison between commercially available assays. PLoS One 5: e11555.
36. Strandhagen E, Berg C, Lissner L, Nunez L, Rosengren A, et al. (2010) Selection bias in a population survey with registry linkage: potential effect on socioeconomic gradient in cardiovascular risk. Eur J Epidemiol 25: 163-72.
37. Bender AM, Jorgensen T, Helbech B, Linneberg A, Pisinger C (2012) Socioeconomic position and participation in baseline and follow-up visits: the Inter99 study. Eur J Prev Cardiol.
38. Nohr EA, Frydenberg M, Henriksen TB, Olsen J (2006) Does low participation in cohort studies induce bias? Epidemiology 17: 413-8. (Pubitemid 44305514)
39. Smith GD, Timpson N, Ebrahim S (2008) Strengthening causal inference in cardiovascular epidemiology through Mendelian randomization. Ann Med 40: 524-41.